Rescentris Delivers CERF Electronic Lab Notebook (ELN) with Strict e-Records Compliance Options for

Leading Biotechnology Companies Choose CERF ELN with New Digital Sign and Witness Capabilities to Minimize Intellectual Property Risks Columbus, OH (PRWEB) November 01, 2011 Rescentris, Inc. today announced that it had delivered its award-winning CERF product to several well-known biotechnology companies with new features for added patent protection. CERF is a scalable, cross-platform electronic lab notebook (ELN) software solution used by life sciences and other R&D organizations that migrated away from paper-based record-keeping to increase efficiency and collaboration. Patents and
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories